Gene Expression Profiling to Treat Brain Cancer
Research Officer in CHeBA’s Genetics & Epigenomics Group, Naga Mutyala, completed her PhD in March 2020 which focused on evaluating a rodent model and novel treatments for glioblastoma, a grade IV brain cancer, using gene expression profiling.
Glioblastoma is the most lethal grade of brain cancer in adults and resultantly has very poor patient outcomes with a med
Blog Category